Clinical use of dornase alpha is associated with a slower rate of FEV1 decline in cystic fibrosis.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: David J Pasta |
| Publication date | March 24, 2011 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |